Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Applied Therapeutics, Inc.

Clinical trials sponsored by Applied Therapeutics, Inc., explained in plain language.

Applied Therapeutics, Inc. APLT NASDAQ

A biopharmaceutical company developing treatments for rare diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 2

Promising drug for rare nerve disease trial pulled before start

Disease control Terminated

This study was designed to test whether the drug govorestat could improve symptoms of Charcot-Marie-Tooth disease caused by sorbitol dehydrogenase deficiency (CMT-SORD), a rare nerve condition. It planned to enroll people aged 16 to 65 and compare govorestat to a placebo over 36 …

Phase: PHASE3 • Sponsor: Applied Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC